Pharmacokinetic Study of SPARC1613 and reference1613 in Subjects With Locally Recurrent or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent or Metastatic Breast Cancer
Interventions: DRUG: SPARC1613|DRUG: Reference1613
Sponsor: Sun Pharma Advanced Research Company Limited